✦ LIBER ✦

Detection of minimal residual disease by mutant p53 immunocytochemistry in acute myelogenous leukemia

✍ Scribed by Kattamis, Antonios C.; Tsangaris, George Th.; Vamvoukakis, John; Moschovi, Maria; Grafakos, Stelios; Tzortzatou-Stathopoulou, Fotini

Publisher: John Wiley and Sons
Year: 2000
Tongue: English
Weight: 385 KB
Volume: 34
Category: Article
ISSN: 0098-1532
DOI: 10.1002/(sici)1096-911x(200002)34:2<153::aid-mpo18>3.0.co;2-q

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Detection of minimal residual disease in

Detection of minimal residual disease in acute leukemia by flow cytometry

✍ Dario Campana; Elaine Coustan-Smith 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 289 KB 👁 1 views

Patients with acute leukemia in clinical remission may still have up to 10 10 residual malignant cells (the upper limit of detection by standard morphologic techniques). Sensitive techniques to detect minimal residual disease (MRD) may allow better estimates of the leukemia burden and help the selec

Detection of minimal residual disease in

Detection of minimal residual disease in acute lymphoblastic leukemia by flow cytometry with monoclonal antibodies

✍ Nobutaka Imamura; Atsushi Kuramoto 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 364 KB 👁 1 views

Quantitation of minimal residual disease

Quantitation of minimal residual disease in t(8;21)-positive acute myelogenous leukemia patients using real-time quantitative RT-PCR

✍ Sugimoto, Takeshi; Das, Hiranmoy; Imoto, Shion; Murayama, Tohru; Gomyo, Hiroshi; 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 104 KB 👁 1 views

t(8;21) is one of the common chromosomal translocations in acute myelogenous leukemia (AML). Using a recently developed real-time quantitative polymerase chain reaction (PCR) system, we analyzed the minimal residual disease (MRD) in bone marrow samples from seven AML patients with t(8;21) at differe

Detection of minimal residual disease by

Detection of minimal residual disease by PCR in childhood T-cell acute lymphoblastic leukemia with TAL1 gene rearrangement: A preliminary report

✍ Kikuchi, Akira; Hanada, Ryoji; Yamamoto, Keiko; Hayashi, Yasuhide 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 63 KB 👁 1 views

Monitoring of minimal residual disease i

Monitoring of minimal residual disease in acute myeloid leukemia with frequent and rare patient-specific NPM1 mutations

✍ Dana Dvorakova; Zdenek Racil; Ivana Jeziskova; Ivo Palasek; Marketa Protivankova 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 138 KB 👁 1 views

Rapid and sensitive minimal residual dis

Rapid and sensitive minimal residual disease detection in acute leukemia by quantitative real-time RT-PCR exemplified by t(12;21) TEL-AML1 fusion transcript

✍ Niels Pallisgaard; Niels Clausen; Henrik Schrøder; Peter Hokland 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 353 KB 👁 1 views

Because previous PCR-based methodologies for detection of minimal residual disease (MRD) in leukemia patients have been too cumbersome to allow for widespread clinical usefulness, we have employed a real-time quantitative PCR (RQ-PCR) system to develop an MRD assay for t(12;21). We initially determi